Gene: GIN1
Official Full Name: gypsy retrotransposon integrase 1provided by HGNC
Gene Summary: Predicted to enable nucleic acid binding activity. Predicted to be involved in DNA integration. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17382 | GIN1 Knockout cell line (HeLa) | Human | GIN1 | 1:3~1:6 | Negative | Online Inquiry |
KO17383 | GIN1 Knockout cell line (HCT 116) | Human | GIN1 | 1:2~1:4 | Negative | Online Inquiry |
KO17384 | GIN1 Knockout cell line (HEK293) | Human | GIN1 | 1:3~1:6 | Negative | Online Inquiry |
KO17385 | GIN1 Knockout cell line (A549) | Human | GIN1 | 1:3~1:4 | Negative | Online Inquiry |
GIN1 Gene Knockout Cell Lines are genetically engineered cell models specifically designed to study the function of the GIN1 gene, which is known to play critical roles in various cellular processes, including cell adhesion, migration, and signal transduction pathways. These cell lines are created through the use of CRISPR/Cas9 technology, which introduces precise mutations that lead to the complete ablation of the GIN1 gene, allowing researchers to investigate phenotypic changes resulting from its loss.
The primary mechanism by which GIN1 Gene Knockout Cell Lines operate involves the disruption of GIN1-related signaling pathways, enabling scientists to dissect the molecular mechanisms underlying physiological and pathological conditions. Researchers can observe alterations in cell behavior, gene expression, and protein interactions in response to the knockout, providing valuable insight into the gene's biological relevance in both normal and disease states.
The scientific importance of GIN1 knockouts lies in their broad application in cancer research, developmental biology, and neurobiology. By elucidating the role of GIN1 in these areas, researchers can potentially identify novel therapeutic targets or biomarkers for diseases, advancing both basic and applied sciences.
What sets GIN1 Gene Knockout Cell Lines apart from alternative models is their unparalleled specificity and reliability. Unlike traditional knockout techniques that may result in off-target effects, CRISPR/Cas9 allows for highly precise gene editing, minimizing unintended alterations. Furthermore, these cell lines are readily available and can be offered in various common cellular backgrounds, facilitating integration into diverse research settings.
Researchers and clinicians will find great value in GIN1 Gene Knockout Cell Lines not only due to their ability to streamline experimental workflows but also because they generate reproducible and reliable data essential for downstream applications. This product empowers the scientific community to explore new frontiers in gene function studies and therapeutic developments.
With a commitment to excellence in gene editing technologies, our company brings extensive expertise in genetic modifications and cell line development, ensuring that GIN1 Gene Knockout Cell Lines meet the highest standards of quality and research utility.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.